LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	GW843682X	0.12	uM	LJP6	72	hr	1334	3380	3925	0.8613	0.8170
BT-20	GW843682X	0.37	uM	LJP6	72	hr	1334	2878	3925	0.7333	0.6384
BT-20	GW843682X	3.33	uM	LJP6	72	hr	1334	1015	3925	0.2587	-0.1618
BT-20	GW843682X	10	uM	LJP6	72	hr	1334	648	3925	0.1652	-0.3713
BT-20	HG-5-113-01	1.11	uM	LJP5	72	hr	1334	2662	4033	0.6595	0.5389
BT-20	HG-5-113-01	3.33	uM	LJP5	72	hr	1334	1876	4033	0.4650	0.2366
BT-20	HG-5-88-01	0.04	uM	LJP6	72	hr	1334	2936	3925	0.7484	0.6596
BT-20	HG-5-88-01	0.12	uM	LJP6	72	hr	1334	3470	3925	0.8843	0.8476
BT-20	HG-5-88-01	3.33	uM	LJP6	72	hr	1334	3499	3925	0.8920	0.8569
BT-20	HG-5-88-01	10	uM	LJP6	72	hr	1334	2250	3925	0.5738	0.3957
BT-20	HG-6-64-01	0.12	uM	LJP6	72	hr	1334	4124	3925	1.0509	1.0647
BT-20	HG-6-64-01	0.37	uM	LJP6	72	hr	1334	4162	3925	1.0599	1.0743
BT-20	Seliciclib	0.04	uM	LJP5	72	hr	1334	4094	4033	1.0156	1.0199
BT-20	Seliciclib	0.12	uM	LJP5	72	hr	1334	4007	4033	0.9941	0.9928
BT-20	Seliciclib	1.11	uM	LJP5	72	hr	1334	3827	4033	0.9489	0.9352
BT-20	Seliciclib	3.33	uM	LJP5	72	hr	1334	3442	4033	0.8529	0.8091
BT-20	AT-7519	0.12	uM	LJP6	72	hr	1334	3834	3925	0.9770	0.9701
BT-20	AT-7519	0.37	uM	LJP6	72	hr	1334	3020	3925	0.7695	0.6901
BT-20	AT-7519	3.33	uM	LJP6	72	hr	1334	350	3925	0.0894	-0.5784
BT-20	AT-7519	10	uM	LJP6	72	hr	1334	285	3925	0.0728	-0.6302
BT-20	AZD7762	1.11	uM	LJP6	72	hr	1334	2258	3925	0.5752	0.4018
BT-20	AZD7762	3.33	uM	LJP6	72	hr	1334	1438	3925	0.3665	0.0491
BT-20	AZD8055	0.04	uM	LJP6	72	hr	1334	2367	3925	0.6035	0.4440
BT-20	Neratinib	0.37	uM	LJP5	72	hr	1334	2977	4033	0.7378	0.6521
BT-20	Neratinib	0.12	uM	LJP5	72	hr	1334	2945	4033	0.7301	0.6414

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)